Outpatient Brexucabtagene Autoleucel in B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma

Am J Hematol. 2025 Oct;100(10):1916-1919. doi: 10.1002/ajh.70038. Epub 2025 Aug 20.

Authors

Tamer Othman^{1

2}, John H Baird¹, Yan Wang³, Stacy Pak⁴, Hannah Zhong¹, Ibrahim Aldoss¹, Ji-Lian Cai¹, Alexey Danilov¹, Tycel J Phillips¹, Vaibhav Agrawal¹, Karamjeet S Sandhu¹, Matthew Mei¹, Paul B Koller¹, Joycelynne Palmer^{1

3}, Stephen J Forman¹, Lihua E Budde¹, Ahmed Aribi¹

Affiliations

¹ Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
² Division of Hematology/Oncology, University of California San Francisco, San Francisco, California, USA.
³ Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA.
⁴ Department of Pharmacy, City of Hope National Medical Center, Duarte, California, USA.

PMID: 40833241
DOI: 10.1002/ajh.70038

No abstract available

Keywords: CAR T; acute lymphoblastic leukemia; brexucabtagene autoleucel; mantle cell lymphoma; outpatient lymphodepletion.

Publication types

Letter